A group of 61 biopharma companies, executives and investors has filed an amicus brief in support of the FDA in an ongoing case brought by Louisiana meant to remove access to the abortion pill mifepristone.
Source: www.fiercehealthcare.com
IKON Portfolio Context
Kynetide Peptides supplies 99%+ HPLC-verified research compounds with batch-specific COAs to 2,400+ researchers worldwide.